Figure 3B shows that ouabain remarkably induced pooled AML cell death (Annexin V+) in a dose- and time-dependent manner, thus validating its cytotoxic effect against AML cells at an early stage. The gene discussed is ANXA5; the disease is acute myeloid leukemia.